Mohideen Pharis's Form 4 filing
DBV Technologies S.A.DBVT · filed Nov 25, 2024
- Accession no.
- 0001415889-24-027648
- Filed
- Nov 25, 2024
- Trade date
- Nov 21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.27K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mohideen PharisCIK 0001760395 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Ordinary Shares | AGrant or awardAcquired | +35,000 | $0.00 | $0 | 114,367 | Direct | |
| Nov 21, 2024 | Ordinary Shares | SSaleDisposed | −2,350 | $0.54F4 | −$1,269 | 112,017 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Ordinary Shares | AGrant or awardAcquired | +215,000 | $0.00 | $0 | 215,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0546 to EURO 1.00 as of November 21, 2024.
Referenced by the price of 1 transaction in Table I.